Proceedings of the American Thoracic Society Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rubin, L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rubin, L. J.
The Proceedings of the American Thoracic Society 3:111-115 (2006)
© 2006 The American Thoracic Society

Pulmonary Arterial Hypertension

Lewis J. Rubin

University of California, San Diego, School of Medicine, La Jolla, California

Correspondence and requests for reprints should be addressed to Lewis J. Rubin, M.D., University of California, San Diego, School of Medicine, 9300 Campus Point Drive, La Jolla, CA 92037. E-mail: ljrubin{at}ucsd.edu

ABSTRACT

Pulmonary arterial hypertension (PAH) is a term used to classify a variety of conditions that have in common an injury to the pulmonary vasculature that produces elevations in pulmonary arterial pressure. There have been considerable advances in our understanding of the pathogenesis and treatment of PAH over the past decade. The article reviews the classification of diseases associated with PAH, the current understanding of its pathogenesis, and the contemporary approach to therapy.

Key Words: endothelin • prostacyclin • pulmonary hypertension




This article has been cited by other articles:


Home page
The Journal of RheumatologyHome page
N. PELED, D. SHITRIT, B. D. FOX, D. SHLOMI, A. AMITAL, D. BENDAYAN, and M. R. KRAMER
Peripheral Arterial Stiffness and Endothelial Dysfunction in Idiopathic and Scleroderma Associated Pulmonary Arterial Hypertension
J Rheumatol, May 1, 2009; 36(5): 970 - 975.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
K. Kamio, X. Liu, H. Sugiura, S. Togo, T. Kobayashi, S. Kawasaki, X. Wang, L. Mao, Y. Ahn, C. Hogaboam, et al.
Prostacyclin Analogs Inhibit Fibroblast Contraction of Collagen Gels through the cAMP-PKA Pathway
Am. J. Respir. Cell Mol. Biol., July 1, 2007; 37(1): 113 - 120.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. E. Morty, B. Nejman, G. Kwapiszewska, M. Hecker, A. Zakrzewicz, F. M. Kouri, D. M. Peters, R. Dumitrascu, W. Seeger, P. Knaus, et al.
Dysregulated Bone Morphogenetic Protein Signaling in Monocrotaline-Induced Pulmonary Arterial Hypertension
Arterioscler. Thromb. Vasc. Biol., May 1, 2007; 27(5): 1072 - 1078.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
P. A. Corris and J. D. Christie
Update in Transplantation 2006
Am. J. Respir. Crit. Care Med., March 1, 2007; 175(5): 432 - 435.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Thoracic Society.
 
ATS Par News